Lundbeck Inc. and CHDI Foundation Announce Research Collaboration to Investigate Candidate Therapy for Huntington’s Disease
DEERFIELD, Ill.--(BUSINESS WIRE)-- CHDI Foundation, Inc. and Lundbeck today announced a research collaboration to investigate a targeted therapy for Huntington’s disease (HD). Currently, no treatment exists to slow or halt the progression of HD,1 a challenging hereditary neurodegenerative disease characterized by a triad of behavioral, cognitive, and motor symptoms.2